Dra. Estela Giménez Quiles

Investigadora Emergente
Grupo de Investigación en Microbiología Molecular y Patogénesis Microbiana

Presentación


Licenciada en Farmacia por la Universitat de Valéncia (2010) y Especialista en Microbiología y Parasitología Clínica (2015) en el Servicio de Microbiología del Hospital Universitario de Valencia. Ha colaborado activamente en el grupo de investigación «Inmunobiología de la infección por el Citomegalovirus (CMV) humano» liderado por el Dr. David Navarro Ortega. Fruto de ello ha sido la publicación de numerosos artículos originales en revistas internacionales de alto impacto y la defensa de la tesis doctoral (2016) titulada “Infección activa por el Citomegalovirus en el Trasplante Alogénico de precursores Hematopoyéticos: Investigación de nuevos factores biológicos para la estimación del riesgo y análisis integral de los mecanismos inmunitarios que la previenen y controlan”. En 2018 obtuvo el premio extraordinario de doctorado. Ha sido beneficiaria de un contrato de formación Río Hortega (2017-2018) de la Acción Estratégica en Salud (AES) del Instituto de Salud Carlos III. Actualmente disfruta de un contrato de incorporación «Juan Rodés» de la Acción Estratégica en Salud (AES) del Instituto de Salud Carlos III en el Servicio de Microbiología del Hospital Clínico Universitario de Valencia.

Dra. Estela Giménez Quiles
Investigadora
Emergente
Dra. Estela Giménez Quiles

egimenez@incliva.es; estela.gimenez.quiles@gmail.com

Publicaciones
A performance comparison of two (Electro) chemiluminescence immunoassays for detection and quantitation of serum anti-spike antibodies according to SARS-CoV-2 vaccination and infections status. Camacho J, Albert E, Zulaica J, Alvarez-Rodriguez B, Rusu L, Olea B, Alcaraz M, Geller R, Gimenez E, Navarro D. Journal of Medical Virology. 2023 Jan;95(1):e28397. doi: 10.1002/jmv.28397. PMID: 36504019

A rapid MALDI-TOF mass spectrometry-based method for categorization of Pseudomonas aeruginosa from blood cultures as susceptible or resistant to meropenem. Sanchez D, Torres I, Gimenez E, Albert E, Costa R, Padron C, Carretero D, Colomina J, Navarro D. Journal of Microbiological Methods. 2023 Aug 6;212:106803. doi: 10.1016/j.mimet.2023.106803. PMID: 37544430

Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant. Camacho J, Gimenez E, Albert E, Zulaica J, Alvarez-Rodriguez B, Torres I, Rusu L, Burgos J, Peiro S, Vanaclocha H, Limon R, Alcaraz M, Sanchez-Paya J, Diez-Domingo J, Comas I, Gonzales-Candelas F, Geller R, Navarro D. Journal of Medical Virology. 2023 Jan;95(1):e28284. doi: 10.1002/jmv.28284. PMID: 36333837

Cytomegalovirus DNAemia in hematological patients undergoing CD19-directed CAR-T cell therapy: should it be systematically monitored?. Solano de la Asuncion C, Hernani R, Albert E, Gomez M, Gimenez E, Benzaquen A, Gonzalez-Barbera E, Hernandez-Boluda J, Perez A, Pinana J, Chorao P, Guerreiro M, Montoro J, Sanz J, Solano C, Navarro D. Clinical Microbiology and Infection. 2023 Aug;29(8):1093-1095. doi: 10.1016/j.cmi.2023.05.010. PMID: 37182642

Dynamics of Human Anelloviruses in plasma and clinical outcomes following kidney transplantation. Forque L, Fernandez-Ruiz M, Albert E, Gimenez E, Monzo C, Chaves J, Redondo N, Rodriguez-Goncer I, Ruiz-Merlo T, Parra P, Andres A, Aguado JM, Navarro D. Transplantation. 2023 Feb 1;107(2):511-520. doi: 10.1097/TP.0000000000004292. PMID: 36042550

Features of cytomegalovirus DNAemia and virus-specific T-cell responses in allogeneic hematopoietic stem-cell transplant recipients during prophylaxis with letermovir. Gimenez E, Guerreiro M, Torres I, Aguilar C, Albert E, Hernandez-Boluda JC, Hernani R, Perez A, Amat P, Pinana JL, Montoro J, Solano C, Navarro D. Transplant Infectious Disease. 2023 Apr;25(2):e14021. doi: 10.1111/tid.14021. PMID: 36748748

Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors. Solano De la Asuncion C, Gimenez E, Hernandez-Boluda JC, Terol MJ, Albert E, Lopez-Jimenez J, Garcia-Gutierrez V, Andreu R, Garcia D, Fox ML, Remigia MJ, Amat P, Solano C, Navarro D. British Journal of Haematology. 2023 Mar;200(6):e58-e61. doi: 10.1111/bjh.18655. PMID: 36652997

Immunovirology of cytomegalovirus infection in allogeneic stem cell transplant recipients undergoing prophylaxis with letermovir: a narrative review. Solano C, Giménez E, Albert E, Piñana J, Navarro D. Journal of Medical Virology. 2023 Aug;95(8):e29005. doi: 10.1002/jmv.29005. PMID: 37526411

Impact of cytomegalovirus immunodominant HLA-I donor-recipient matching on the incidence and features of virus DNAemia and virus-specific T-cell immune reconstitution in unmanipulated haploidentical hematopoietic stem cell transplantation. Huntley D, Gimenez E, Vazquez L, Pascual M, Amat P, Remigia M, Hernandez-Boluda J, Garcia M, Gago B, Torres I, de la Asuncion C, Hernani R, Perez A, Albert E, Pinana J, Solano C, Navarro D. Transplant Infectious Disease. 2023 Jun;25(3):e14065. doi: 10.1111/tid.14065. PMID: 37120821

In vitro assessment of the combined effect of letermovir and sirolimus on cytomegalovirus replication. Gimenez E, Guerreiro M, Gozalbo-Rovira R, Aguilar C, Albert E, Pinana J, Solano C, Navarro D. Revista Espanola de Quimioterapia. 2023 Oct;36(5):526-530. doi: 10.37201/req/016.2023. PMID: 37365797

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and lateral flow immunochromatography for rapid identification of beta-lactamase-gene-harboring Enterobacterales in urine specimens: Performance and cost-benefit analyses. Sánchez D, Torres I, Padrón C, Giménez E, Colomina J, Carretero D, Buesa J, Navarro D, Albert E. Diagnostic Microbiology and Infectious Disease. 2023 Oct 30;108(2):116127. doi: 10.1016/j.diagmicrobio.2023.116127. PMID: 37988931

Monitoring of plasma Torque teno virus, total Anelloviridae and Human Pegivirus 1 viral load for the prediction of infectious events and acute graft versus host disease in the allogeneic hematopoietic stem cell transplantation setting. Forqué L, Albert E, Piñana JL, Pérez A, Hernani R, Solano C, Navarro D, Giménez E. Journal of Medical Virology. 2023 Sep;95(9):e29107. doi: 10.1002/jmv.29107. PMID: 37721473

Multi-site performance evaluation of the Alinity m Molecular assay for quantifying Epstein-Barr virus DNA in plasma samples. Wessels E, Albert E, Vreeswijk T, Claas E, Gimenez E, Reinhardt B, Sasaki M, Navarro D. Journal of Clinical Microbiology. 2023 Oct 24;61(10):e0047223. doi: 10.1128/jcm.00472-23. PMID: 37728343

Multicenter performance evaluation of the Alinity m CMV assay for quantifying cytomegalovirus DNA in plasma samples. Lee M, Albert E, Wessels E, Kim S, Chung H, Gimenez E, Vreeswijk T, Claas E, Tai Y, Reinhardt B, Sasaki M, Navarro D. Journal of Clinical Microbiology. 2023 Oct 24;61(10):e0041523. doi: 10.1128/jcm.00415-23. PMID: 37728341

Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naive individuals in the general population. Camacho J, Zulaica J, Gimenez E, Rusu L, Velandia-Alvarez S, Albert E, Peiro S, Vanaclocha H, Limon R, Geller R, Navarro D. Journal of Infection. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2022.12.029. PMID: 36599404

Seroprevalence of antibodies against SARS-CoV-2 in the Valencian Community (Spain) as of October 2022. Garcia-Sempere A, Gimenez E, Vanaclocha H, Limon R, Peiro S, Navarro D. Gaceta Sanitaria. 2023 May 18;37:102312. doi: 10.1016/j.gaceta.2023.102312. PMID: 37331154

The Biofire Filmarray Pneumonia Plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: a diagnostic and cost-benefit evaluation. Ferrer J, Clari M, Gimenez E, Carbonell N, Torres I, Blasco M, Albert E, Navarro D. Diagnostic Microbiology and Infectious Disease. 2023 Feb;105(2):115847. doi: 10.1016/j.diagmicrobio.2022.11584. PMID: 36403558

The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmisión. Soriano-Ramos M, Esquivel-De la Fuente E, Vicent E, de la Calle M, Baquero-Artigao F, Dominguez-Rodriguez S, Cabanes M, Gomez-Montes E, Gonce A, Valdes-Bango M, Vinuela-Beneitez M, Gutierrez M, Saavedra-Lozano J, Perez I, Encinas B, Vilella L, Martfnez M, Tagarro A, Rodriguez-Molino P, Quiles E, Alcazar D, Burguillo A, Folgueira M, Navarro D, Blazquez-Gamero D. PLoS One. 2023 Feb 6;18(2):e0281341. doi: 10.1371/journal.pone.0281341. PMID: 36745589

Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy. Benzaquén A, Giménez E, Iacoboni G, Guerreiro M, Hernani R, Albert E, Carpio C, Balaguer A, Pérez A, S de la Asunción C, Sánchez-Salinas MA, Chorão P, Piñana JL, Beas F, Montoro J, Hernández-Boluda JC, Facal A, Ferrer B, Villalba M, Amat P, Goméz MD, Campos D, Terol MJ, Sanz J, Barba P, Navarro D, Solano C. Bone Marrow Transplantation. 2023 Nov 2. doi: 10.1038/s41409-023-02114-0. PMID: 37919456

BD MAX enteric bacterial, bacterial plus, and virus panels for diagnosis of acute infectious gastroenteritis: a cost-benefit analysis. Ferrer J, Gimenez E, Carretero D, Buesa J, Morillas F, Granell R, Fuenmayor A, Navarro D, Albert E. Microbiology Spectrum. 2022 Oct 26;10(5):e0088022. doi: 10.1128/spectrum.00880-22. PMID: 36069590

Combined kinetic analysis of SARS-CoV-2 RNAemia, N-antigenemia and virus-specific antibodies in critically ill adult COVID-19 patients. Costa R, Alberola J, Olea B, Gozalbo-Rovira R, Gimenez E, Cuevas-Ferrando E, Torres I, Albert E, Carbonell N, Ferreres J, Sanchez G, Rodriguez-Diaz J, Blasco M, Navarro D. Scientific Reports. 2022 May 18;12(1):8273. doi: 10.1038/s41598-022-12461-5. PMID: 35585163

Dynamics of SARS-CoV-2-Spike-reactive antibody and T-cell responses in chronic kidney disease patients within 3 months after COVID-19 full vaccination. Panizo N, Albert E, Gimenez-Civera E, Puchades M, D’Marco L, Gandia-Salmeron L, Gimenez E, Torre I, Sancho A, Gavela E, Gonzalez-Rico M, Montomoli M, Perez-Baylach C, Bonilla B, Solano C, Alvarado M, Torregrosa I, Alcaraz M, Gorriz J, Navarro D. Clinical Kidney Journal. 2022 Apr 9;15(8):1562-1573. doi: 10.1093/ckj/sfac093. PMID: 35880064

Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty COVID-19 vaccine. Gimenez E, Alberola J, Torres I, Albert E, Alcaraz MJ, Botija P, Amat P, Remigia MJ, Beltran MJ, Rodado C, Huntley D, Olea B, Navarro D. Journal of Infection. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.10.026. PMID: 34740744

Human pegivirus type 1 infection in kidney transplant recipients: replication kinetics and clinical correlates. Fernandez-Ruiz M, Forque L, Albert E, Redondo N, Gimenez E, Lopez-Medrano F, Gonzalez E, Polanco N, Ruiz-Merlo T, Parra P, San Juan R, Andres A, Aguado J, Navarro D. Transplant Infectious Disease. 2022 Feb;24(1):e13771. doi: 10.1111/tid.13771. PMID: 34921747

Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty COVID-19 vaccine in nursing home residents. Albert E, Burgos JS, Peiro S, Salas D, Vanaclocha H, Gimenez E, Limon R, Alcaraz MJ, Sanchez-Paya J, Diez-Domingo J, Cervantes A, Navarro D. Clinical Microbiology and Infection. 2022 Feb;28(2):279-284. doi: 10.1016/j.cmi.2021.09.031. PMID: 34619398

Impact of polymorphisms in genes orchestrating innate immune responses on replication kinetics of Torque teno virus after kidney transplantation. Redondo N, Rodriguez-Goncer I, Parra P, Albert E, Gimenez E, Ruiz-Merlo T, Lopez-Medrano F, San Juan R, Gonzalez E, Sevillano A, Andres A, Navarro D, Aguado J, Fernandez-Ruiz M. Frontiers in Genetics. 2022 Nov 22;13:1069890. doi: 10.3389/fgene.2022.1069890. PMID: 36482892

Monitoring of Torque Teno virus DNAemia in critically ill COVID-19 patients: may it help to predict clinical outcomes?. Forque L, Albert E, Gimenez E, Torres I, Carbonell N, Ferreres J, Blasco M, Navarro D. Journal of Clinical Virology. 2022 Jan 23;148:105082. doi: 10.1016/j.jcv.2022.105082. PMID: 35091226

Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents. Sánchez-Sendra B, Albert E, Zulaica J, Torres I, Giménez E, Botija P, Beltrán MJ, Rodado C, Geller R, Navarro D. Scientific Reports. 2022 Mar 8;12(1):3788. doi: 10.1038/s41598-022-07849-2. PMID: 35260713

Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-gamma-producing T cells after COVID-19 vaccination. Tormo N, Gimenez E, Martinez-Navarro M, Albert E, Navalpotro D, Torres I, Gimeno C, Navarro D. European Journal of Clinical Microbiology & Infectious Diseases. 2022 Apr;41(4):657-662. doi: 10.1007/s10096-022-04422-7. PMID: 35165804

SARS-CoV-2 adaptive immunity in nursing home residents following a third dose of the Comirnaty COVID-19 vaccine. Gimenez E, Albert E, Zulaica J, Torres I, Rusu L, Rodriguez Moreno A, Burgos JS, Peiro S, Salas D, Vanaclocha H, Limon R, Alcaraz MJ, Sanchez-Paya J, Diez-Domingo J, Comas I, Gonzales Candelas F, Geller R, Navarro D. Clinical Infectious Diseases. 2022 Aug 24;75(1):e865-e868. doi: 10.1093/cid/ciac223. PMID: 35314856

SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty COVID-19 vaccine. Gimenez E, Albert E, Burgos JS, Peiro S, Salas D, Vanaclocha H, Limon R, Alcaraz MJ, Sanchez Paya J, Diez Domingo J, Comas I, Gonzales Candelas F. Journal of infection. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.02.035. PMID: 35245583

SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty (R) COVID-19 vaccine: looking for correlates of protection. Torres I, Gimenez E, Albert E, Zulaica J, Alvarez-Rodriguez B, Burgos J, Peiro S, Limon R, Vanaclocha H, Rodado C, Botija P, Sifre A, Tur B, Lozano R, Orosa I, Vicente-Ruiz M, Carrion R, Clari M, Sanchez-Paya J, Diez-Domingo J, Comas I, Gonzalez-Candelas F, Geller R, Navarro D. Journal of Medical Virology. 2022 Sep;94(9):4216-4223. doi: 10.1002/jmv.27867. PMID: 35585782

SARS-CoV-2-reactive IFN-gamma-producing CD4+ and CD8+ T cells in blood do not correlate with clinical severity in unvaccinated critically ill COVID-19 patients. Olea B, Albert E, Gimenez E, Torres I, Amat P, Remigia M, Alberola J, Carbonell N, Ferreres J, Blasco M, Navarro D. Scientific Reports. 2022 Aug 22;12(1):14271. doi: 10.1038/s41598-022-18659-x. PMID: 35995830

SARS-CoV-2-spike antibody and T-Cell responses elicited by a homologous third mRNA COVID-19 dose in hemodialysis and kidney transplant recipients. Panizo N, Gimenez E, Albert E, Zulaica J, Rodriguez-Moreno A, Rusu L, Gimenez-Civera E, Puchades M, D’Marco L, Gandia-Salmeron L, Torres I, Sancho A, Gavela E, Gonzalez-Rico M, Montomoli M, Perez-Baylach C, Bonilla B, Solano C, Alvarado M, Torregrosa I, Gonzales-Candia B, Alcaraz M, Geller R, Gorriz J, Navarro D. Microorganisms. 2022 Nov 16;10(11):2275. doi: 10.3390/microorganisms10112275. PMID: 36422345

An investigation of the potential association between gastrointestinal viral and bacterial infection and development of intestinal acute graft versus host disease following allogeneic hematopoietic stem cell transplantation. Bueno F, Albert E, Gimenez E, Pinana J, Perez A, Gomez M, Hernandez-Boluda J, Gonzalez-Barbera E, Montoro J, Buesa J, Guerreiro M, Balaguer-Rosello A, Hernani R, Sanz J, Solano C, Navarro D. Journal of Medical Virology. 2021 Aug;93(8):4773-4779. doi: 10.1002/jmv.26892. PMID: 33605457

B and T cell immune responses elicited by the Comirnaty COVID-19 vaccine in nursing home residents. Torres I, Albert E, Gimenez E, Alcaraz MJ, Botija P, Amat P, Remigia MJ, Beltran MJ, Rodado C, Huntley D, Olea B, Navarro D. Clinical Microbiology and Infection. 2021 Nov;27(11):1672-1677. doi: 10.1016/j.cmi.2021.06.013. PMID: 34174397

Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment. Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Calvo C, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta A, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta M, Pinana J, Navarro D, Spanish Group of Hematopoietic Transplantation and Cell Therapy (GETH). Bone Marrow Transplantation. 2021 Jun;56(6):1281-1290. doi: 10.1038/s41409-020-01157-x. PMID: 33319853

Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group. Solano Vercet C, Vazquez L, Gimenez Quiles E, De La Camara R, Albert Vicent E, Rovira M, Espigado I, Calvo C, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez Martinez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta A, Torrado T, Bautista G, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta M, Pinana J, Navarro Ortega D. American Journal of Transplantation. 2021 Jan;21(1):258-271. doi: 10.1111/ajt.16147. PMID: 32812351

Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib. De la Asuncion C, Terol M, Saus A, Olea B, Gimenez E, Albert E, Lopez-Jimenez J, Andreu R, Garcia D, Fox L, Remigia M, Amat P, Solano C, Navarro D. British Journal of Haematology. 2021 Nov;195(4):637-641. doi: 10.1111/bjh.17732. PMID: 34402042

Diversity and dynamic changes of Anelloviruses in plasma following Allogeneic Hematopoietic Stem Cell Transplantation. Gimenez Quiles E, Monzo Cataluña C, Albert Vicent E, Fuentes Trillo A, Seda García E, Pinana J, Hernandez Boluda J, Solano Vercet C, Chaves Martínez F, Navarro Ortega D. Journal of Medical Virology. 2021 Aug;93(8):5167-5172. doi: 10.1002/jmv.26661. PMID: 33174620

Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children. Costa R, Bueno F, Gimenez E, Bracho A, Albert E, Carretero D, de Michelena P, Martinez-Costa C, Gonzalez-Candelas F, Navarro D. Journal of Infection. 2021 Oct;83(4):496-522. doi: 10.1016/j.jinf.2021.08.015. PMID: 34390756

Performance of a MALDI-TOF mass spectrometry-based method for rapid detection of third-generation oxymino-cephalosporin-resistant Escherichia coli and Klebsiella spp. from blood cultures. Torres I, Albert E, Gimenez E, Olea B, Valdivia A, Pascual T, Huntley D, Sanchez D, Costa RM, Pinto C, Oltra R, Colomina J, Navarro D. European Journal of Clinical Microbiology & Infectious Diseases. 2021 Sep;40(9):1925-1932. doi: 10.1007/s10096-021-04251-0. PMID: 33876385

SARS-CoV-2-reactive interferon-gamma-producing CD8+ T cells in patients hospitalized with Coronavirus Disease 2019. Gimenez Quiles E, Albert Vicent E, Torres Fink I, Remigia Pellicer M, Alcaráz Soriana M, Galindo Puerto M, Blasco Cortes M, Solano Vercet C, Forner Giner M, Redón Mas J, Signes-Costa Miñana J, Navarro Ortega D. Journal of Medical Virology. 2021 Jan;93(1):375-382. doi: 10.1002/jmv.26213. PMID: 32579268

SARS-CoV-2-specific cell-mediated immunity in kidney transplant recipients recovered from COVID-19. Fernandez-Ruiz M, Olea B, Gimenez E, Laguna-Goya R, Trujillo H, Caravaca-Fontan F, Gutierrez E, Lopez-Medrano F, Remigia M, Almendro-Vazquez P, Polanco N, Gonzalez E, Ruiz-Merlo T, Parra P, San Juan R, Andres A, Navarro D, Aguado J. Transplantation. 2021 Jun 1;105(6):1372-1380. doi: 10.1097/TP.0000000000003672. PMID: 33729741

Suitability of Two Rapid Lateral Flow Immunochromatographic Assays for Predicting SARS-CoV-2 Neutralizing Activity of Sera. Valdivia A, Torres I, Latorre V, Frances-Gomez C, Ferrer J, Forque L, Costa R, de la Asuncion C, Huntley D, Gozalbo-Rovira R, Buesa J, Gimenez E, Rodriguez-Diaz J, Geller R, Navarro D. Journal of Medical Virology. 2021 Apr;93(4):2301-2306. doi: 10.1002/jmv.26697. PMID: 33236799

T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19. Fernandez-Ruiz M, Olea B, Almendro-Vazquez P, Gimenez E, Marcacuzco A, San Juan R, Justo I, Calvo-Pulido J, Garcia-Sesma A, Manrique A, Caso O, Cambra F, Talayero P, Lopez-Medrano F, Remigia MJ, Ruiz-Merlo T, Parra P, Paz-Artal E, Jimenez C, Loinaz C, Navarro D, Laguna-Goya R, Aguado JM. American Journal of Transplantation. 2021 Aug;21(8):2785-2794. doi: 10.1111/ajt.16708. PMID: 34092033

Proyectos
Referencia: PI21/00563
Título: Inmunidad adaptativa de linfocitos B y T frente a SARS-CoV-2 tras la vacunación de pacientes en riesgo de sufrir COVID-19 severa
Entidad Financiadora: Instituto de Salud Carlos III – Cofinanciado FEDER
Investigador principal: David Navarro Ortega, Estela Giménez
Duración: 2022 – 2024
Presupuesto: 169.400 €
Referencia: PI-2021-004
Título: TECO: Validación de dos sistemas biosensor para la diagnosis simultánea de covid19 y otros patógenos aéreos
Entidad Financiadora: Universidad de Valencia – INCLIVA
Investigador principal: David Giménez Romero, Estela Giménez Quiles
Duración: 2021 – 2022
Presupuesto: 19.000 €
Referencia: GV/2020/188
Título: Anellovirus y Pegivirus un posible marcador del estado neto de inmunosupresión: evaluación en el trasplante alogénico de progenitores hematopoyéticos
Entidad Financiadora: Conselleria de Educación, Cultura y Deporte
Investigador principal: Estela Giménez Quiles
Duración: 2020 – 2021
Presupuesto: 16.000 €